Summary & Overview
HCPCS G9931: CHA2DS2-VASc Low Risk Documentation
HCPCS Level II code G9931 denotes documentation of a CHA2DS2-VASc risk score indicating low stroke risk: 0 or 1 for men, and 0, 1, or 2 for women. The code captures a discrete clinical finding used in stroke-risk stratification for patients with atrial fibrillation and informs anticoagulation decision pathways. Nationally, standardized documentation of CHA2DS2-VASc supports quality measurement, care coordination, and risk-based treatment planning.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage and billing practices for G9931 vary across payers; payers may use the code for quality reporting, population health workflows, or to support care management programs.
Readers will find an overview of the code's clinical role, common service settings, and the policy context that shapes its use. The publication summarizes how G9931 fits into clinical documentation workflows, highlights typical billing considerations, and outlines where data are available or absent. This material is intended to inform clinicians, billers, and policy stakeholders about the purpose and practical implications of capturing low CHA2DS2-VASc scores in the medical record using HCPCS Level II code G9931.
Billing Code Overview
HCPCS Level II code G9931 documents the CHA2DS2-VASc risk score when the calculated score is 0 or 1 for men, or 0, 1, or 2 for women. This code represents a structured clinical assessment of stroke risk in patients with atrial fibrillation or other conditions where CHA2DS2-VASc scoring is appropriate.
Service type: Risk stratification / clinical risk assessment
Typical site of service: Outpatient clinic or ambulatory care setting, where clinicians perform chart review and clinical calculation of stroke risk as part of medical decision-making or care management.
Clinical & Coding Specifications
Clinical Context
A 68-year-old female patient with a history of paroxysmal atrial fibrillation presents to a cardiology clinic for anticoagulation assessment after recent cardiology referral. The clinician documents a focused history including age, heart failure history, hypertension, diabetes status, prior stroke or transient ischemic attack, vascular disease, and sex category to calculate the CHA2DS2‑VASc score. The clinical workflow includes verifying medical record problem list and prior imaging/lab results, reviewing medications, calculating and documenting the CHA2DS2‑VASc score in the chart, and recording that the score is 0, 1 (for men), or 0, 1, or 2 (for women) as appropriate. Typical site of service is outpatient cardiology or primary care clinic; the service is performed during an evaluation visit or anticoagulation management encounter. Common scenario: clinician documents a low-risk CHA2DS2‑VASc score to support decision-making about initiating or withholding long-term oral anticoagulation; documentation is entered into the EHR problem list, visit note, and billing record to support use of G9931.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural service | Use when documentation supports substantially greater work beyond typical documentation for score calculation or counseling. |
23 | Unusual anesthesia | Not typically used for this nonprocedural service; rarely applicable. |
52 | Reduced services | Use if the CHA2DS2‑VASc documentation was partially completed or limited by patient factors. |
53 | Discontinued procedure | Use if the visit was terminated before score documentation was completed. |
54 | Surgical care only | Not applicable for this evaluation/documentation service. |
55 | Postoperative management only | Not applicable for this outpatient risk-score documentation. |
56 | Preoperative management only | Use if score documentation was performed solely as preoperative risk assessment. |
62 | Two surgeons | Not applicable for this service. |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery | Not applicable for this service. |
CO | Payment adjustment for managed care plan | Use when the patient is covered by a specific managed care arrangement requiring this modifier per payer rules. |
CQ | Registered nurse in ambulatory surgery center | Rarely applicable; not typical for this outpatient documentation. |
FX | Modifier for specific payer billing requirements | Use only if a payer (e.g., Blue Cross Blue Shield plan) requires FX for certain documentation billing rules. |
FY | Replaced by another modifier per payer rules | Use per payer-specific guidance when required. |
QK | Medical direction of two, three, or four CRNAs | Not applicable for this service. |
QX | CRNA service with medical direction by physician | Not applicable for this service. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207RC0000X | Cardiology | Cardiologists commonly calculate and document CHA2DS2‑VASc for atrial fibrillation management. |
| 207RH0000X | Electrophysiology | Cardiac electrophysiologists evaluate stroke risk and anticoagulation strategy in AF patients. |
| 208D00000X | Family Medicine | Primary care clinicians frequently perform risk scoring during routine visits. |
| 207L00000X | Internal Medicine | Internists document CHA2DS2‑VASc when managing chronic atrial fibrillation and anticoagulation. |
| 363A00000X | Nurse Practitioner | Advanced practice clinicians in outpatient settings commonly document the score. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
I48.0 | Paroxysmal atrial fibrillation | Atrial fibrillation subtype commonly prompting CHA2DS2‑VASc scoring to assess stroke risk and need for anticoagulation. |
I48.1 | Persistent atrial fibrillation | Persistent AF patients require stroke-risk stratification with CHA2DS2‑VASc. |
I48.2 | Chronic atrial fibrillation | Chronic AF is an indication for routine CHA2DS2‑VASc assessment. |
I48.91 | Unspecified atrial fibrillation | When AF is documented without further classification, CHA2DS2‑VASc guides anticoagulation decisions. |
I63.9 | Cerebral infarction, unspecified | History of ischemic stroke or TIA increases CHA2DS2‑VASc score and is directly relevant to risk calculation. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
99213 | Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes | Common visit code during which CHA2DS2‑VASc score is calculated and documented for anticoagulation decision-making. |
99214 | Office or other outpatient visit for the evaluation and management of an established patient, typically 25 minutes | Used when documentation includes expanded history, medical decision-making, and counseling related to stroke risk and anticoagulation. |
93797 | Ambulatory blood pressure monitoring, unattended (device record review) — (example related cardiovascular monitoring) | May be performed in the same episode of care for cardiovascular risk assessment; not directly the CHA2DS2‑VASc calculation but part of cardiovascular evaluation. |
93228 | External electrocardiographic recording up to 48 hours by continuous rhythm recording and storage (Holter) | Performed before or after risk assessment for arrhythmia characterization; supports overall AF management. |
99406 | Smoking and tobacco-use cessation counseling, intermediate, greater than 3 minutes up to 10 minutes | Often provided alongside stroke-risk counseling in cardiovascular preventive care visits. |